Dagrun Slettebø  Daltveit's picture

Dagrun Slettebø Daltveit

PhD Candidate
  • E-mailDagrun.Daltveit@uib.no
  • Phone+47 55 58 85 36
  • Visitor Address
    Alrek helseklynge, blokk D, Årstadveien 17
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • Show author(s) 2020. Maternal health, in-utero, and perinatal exposures and risk of thyroid cancer in offspring: a Nordic population-based nested case-control study. The Lancet Diabetes and Endocrinology. 94-105.
  • Show author(s) 2020. Cancer risk in individuals with major birth defects: large Nordic population based case-control study among children, adolescents, and adults. The BMJ. 14 pages.
  • Show author(s) 2019. The effect of a multicomponent intervention on quality of Life in residents of nursing homes: A randomized controlled trial (COSMOS). Journal of the American Medical Directors Association. 330-339.
  • Show author(s) 2019. Quality of Life and Pain Medication Use in Persons With Advanced Dementia Living in Long-Term Care Facilities. Journal of the American Medical Directors Association. 1432-1437.
  • Show author(s) 2018. Tolerability of buprenorphine transdermal system in nursing home patients with advanced dementia: a randomized, placebo-controlled trial (DEP.PAIN.DEM). Clinical Interventions in Aging. 935-946.
  • Show author(s) 2018. Efficacy and Safety of Analgesic Treatment for Depression in People with Advanced Dementia: Randomised, Multicentre, Double-Blind, Placebo-Controlled Trial (DEP.PAIN.DEM). Drugs & Aging. 545-558.
  • Show author(s) 2018. Authors’ Reply to Stefani: “Efficacy and Safety of Analgesic Treatment for Depression in People with Advanced Dementia: Randomised, Multicentre, Double-Blind, Placebo-Controlled Trial (DEP.PAIN.DEM)”. Drugs & Aging. 1121-1122.
  • Show author(s) 2017. Associations between pain and depression in nursing home patients at different stages of dementia. Journal of Affective Disorders. 8-14.

More information in national current research information system (CRIStin)

Cancer risk in families with children with birth defects

In this project, we take advantage of large population-based registries in four Nordic countries to explore the relationship between birth defects and cancer risk in more detail, and more extensively, than previously done. Whether birth defect(s) is associated with cancer risk in the affected individual and their families is important for the understanding of the etiology of specific cancers and could possibly allow for identification of individuals at elevated risk who would benefit from more regular follow-up or subsequent clinical intervention.

Perinatal characteristics and thyroid cancer risk in mothers and offspring: a Nordic registry linkage study

A Nordic birth and cancer registry linkage study to prospectively evaluate the associations of pregnancy complications and other perinatal characteristics with subsequent risk of thyroid cancer in women (subproject 1) and their offspring (subproject 2).  We hypothesize that benign thyroid disorders during pregnancy, particularly hypothyroidism (underactive thyroid) and perinatal characteristics related to or a consequence of underactive thyroid (e.g., preterm birth, gestational hypertension/preeclampsia, gestational diabetes, placental abruption) and/or altered sex steroid hormones during pregnancy (e.g., extreme birth weight, preterm birth, twin pregnancy, low birth order, hyperemesis, gestational hypertension/preeclampsia, pre-pregnancy and pregnancy weight and weight gain (10)) are associated with increased risk of thyroid cancer in both mothers and their offspring. 

Development of job-exposure-models for risk assessment of benzene exposure

The primary objective is to develop task- and job-exposure models to estimate benzene exposure by inhalation among the five job categories assumed to have the highest exposure at oil and gas processing installations.